What is the purpose of this trial?
The purpose of this study is to determine whether AB103 is safe and effective in the treatment of patients with necrotizing soft tissue infections receiving standard of care therapy.
Ages: 12 years and older
Dates: 10/26/2015 - 09/30/2017
Last Updated: 08/03/2016
Study HIC#: 1507016217